References
- Atanackovic, D., Nierhaus, A., Neumeier, M., Hossfeld, D K., Hegewisch-Becker, S. (2002). 41.8 whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases. Cancer Immunol. Immunother. 51(11–12):603–613. [PUBMED], [INFOTRIEVE], [CSA]
- Binder, R J., Blachere, N E., Srivastava, P K. (2001). Heat shock protein-chaperoned peptides but not free peptides introduced into the cytosol are presented efficiently by major histocom patibility complex I molecules. J. Biol. Chem. 276(20):17163–17171. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Black, A R., Subjeck, J R. (1991). The biology and physiology of the heat shock and glucose-regulated stress protein systems. Methods Achiev. Exp. Pathol. 15:126–166. [PUBMED], [INFOTRIEVE]
- Burd, R., Dziedzic, T S., Xu, Y., Caligiuri, M A., Subjeck, J R., Repasky, E A. (1998). Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia. J. Cell. Physiol. 177(1):137–147. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Castellino, F., Boucher, P E., Eichelberg, K., Mayhew, M., Rothman, J E., Houghton, A N., Germain, R N. (2000). Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways. J. Exp. Med. 191(11):1957–1964., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Chandawarkar, R Y., Wagh, M S., Srivastava, P K. (1999). The dual nature of specific immunological activity of tumor-derived gp96 preparations. J. Exp. Med. 189:1437–1442. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Chen, X., Tao, Q., Yu, H., Zhang, L., Cao, X. (2002). Tumor cell membrane-bound heat shock protein 70 elicits antitumor immunity. Immunol. Lett. 84(2):81–87. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Di, Y P., Repasky, E A., Subjeck, J R. (1997). Distribution of HSP70, protein kinase C, and spectrin is altered in lymphocytes during a fever-like hyperthermia exposure. J. Cell. Physiol. 172(1):44–54. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Evans, S S., Wang, W C., Bain, M D., Burd, R., Ostberg, J R., Repasky, E A. (2001). Fever-range hyperthermia dynamically regulates lymphocyte delivery to high endothelial venules. Blood 97(9):2727–2733. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Falk, M H., Issels, R D. (2001). Hyperthermia in oncology. Int. J. Hypertherm. 17(1):1–18. [CSA], [CROSSREF]
- Hightower, L E. (1991). Heat shock, stress proteins, chaperones, and proteotoxicity. Cell 66(2):191–197. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hildebrandt, B., Wust, P., Ahlers, O., Dieing, A., Sreenivasa, G., Kerne, T., Felix, R., Riess, H. (2002). The cellular and molecular basis of hyperthermia. Crit. Rev. Oncol./Hematol. 43(1):33–56. [CROSSREF]
- Hsu, K F., Hung, C F., Cheng, W F., He, L., Slater, L A., Ling, M., Wu, T C. (2001). Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen. Gene Ther. 8(5):376–383. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ishii, T., Udono, H., Yamano, T., Ohta, H., Uenaka, A., Ono, T., Hizuta, A., Tanaka, N., Srivastava, P K., Nakayama, E. (1999). Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96. J. Immunol. 162(3):1303–1309. [PUBMED], [INFOTRIEVE]
- Kiang, J G., Tsokos, G C. (1998). Heat shock protein 70 kDa: molecular biology, biochemistry, and physiology. Pharmacol. Ther. 80(2):183–201. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Knox, J D., Mitchel, R E., Brown, D L. (1991). Effects of hyperthermia on microtubule organization and cytolytic activity of murine cytotoxic T lymphocytes. Exp. Cell Res. 194(2):275–283. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kraybill, W G., Olenki, T., Evans, S S., Ostberg, J R., O'Leary, K A., Gibbs, J F., Repasky, E A. (2002). A phase I study of fever-range whole body hyperthermia (FR-WBH) inpatients with advanced solid tumours: correlation with mouse models. Int. J. Hypertherm. 18(3):253–266. [CSA], [CROSSREF]
- Leon, S A., Asbell, S O., Edelstein, G., Arastu, H H., Daskal, I., Sheehan, S., Plunkett, D M., Guttmann, G G., Packel, A J., Leon, O. (1993). Effects of hyperthermia on bone. I. Heating rate patterns induced by microwave irradiation in bone and muscle phantoms. Int. J. Hypertherm. 9(1):69–75.
- Li, D J., Zhou, S L., Qiu, S L., Qiao, S J. (1987). Thermodamage, thermosensitivity and thermotolerance on normal swine esophagus. Int. J. Hypertherem. 3(2):142–151.
- Li, D J., Qiu, S L., Zhou, S L., Liu, H L. (1988). Acute heat injury to the normal swine rectum. Int. J. Hypertherem. 4(2):191–201.
- MacDonald, H R. (1977). Effect of hyperthermia on the functional activity of cytotoxic T-lymphocytes. J. Natl. Cancer Inst. 59(4):1263–1268. [PUBMED], [INFOTRIEVE]
- Manjili, M H., Wang, X Y., Park, J., Facciponte, J G., Repasky, E A., Subjeck, J R. (2002). Immunotherapy of cancer using heat shock proteins. Front. Biosci. 7:d43–d52., [PUBMED], [INFOTRIEVE], [CSA]
- Manjili, M H., Wang, X Y., Chen, X., Martin, T., Repasky, E A., Henderson, R., Subjeck, J R. (2003). HSP110-HER2/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors in HER-2/neu transgenic mice. J. Immunol. 171(8):4054–4061. [PUBMED], [INFOTRIEVE]
- Massa, C., Guiducci, C., Arioli, I., Parenza, M., Colombo, M P., Melani, C. (2004). Enhanced efficacy of tumor cell vaccines transfected with secretable hsp70. Cancer Res. 64(4):1502–1508. [PUBMED], [INFOTRIEVE]
- Matsuda, H., Strebel, F R., Kaneko, T., Danhauser, L L., Jenkins, G N., Toyota, N., Bull, J M. (1997). Long duration-mild whole body hyperthermia of up to 12 hours in rats: feasibility, and efficacy on primary tumour and axillary lymph node metastases of a mammary adenocarcinoma: implications for adjuvant therapy. Int. J. Hypertherm. 13(1):89–98. [CSA]
- Oki, Y., Younes, A. (2004). Heat shock protein-based cancer vaccines. Expert Rev. Vaccines 3(4):403–411. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ostberg, J R., Repasky, E A. (2000a). Comparison of the effects of two different whole body hyperthermia protocols on the distribution of murine leukocyte populations. Int. J. Hypertherm. 16(1):29–43. [CSA], [CROSSREF]
- Ostberg, J R., Repasky, E A. (2000b). Use of mild, whole body hyperthermia in cancer therapy. Immunol. Invest. 29(2):139–142. [PUBMED], [INFOTRIEVE], [CSA]
- Ostberg, J R., Patel, R., Repasky, E A. (2000). Regulation of immune activity by mild (fever-range) whole body hyperthermia: effects on epidermal Langerhans cells. Cell Stress Chaperones 5(5):458–461. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ostberg, J R., Gellin, C., Patel, R., Repasky, E A. (2001). Regulatory potential of fever-range whole body hyperthermia on Langerhans cells and lymphocytes in an antigen-dependent cellular immune response. J. Immunol. 167(5):2666–2670. [PUBMED], [INFOTRIEVE]
- Ostberg, J R., Kaplan, K C., Repasky, E A. (2002). Induction of stress proteins in a panel of mouse tissues by fever-range whole body hyperthermia. Int. J. Hypertherm. 18(6):552–562. [CSA], [CROSSREF]
- Overgaard, J., Gonzalez Gonzalez, D., Hulshof, M C., Arcangeli, G., Dahl, O., Mella, O., Bentzen, S M. (1995). Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet 345(8949):540–543. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Overgaard, J., Gonzalez Gonzalez, D., Hulshof, M C., Arcangeli, G., Dahl, O., Mella, O., Bentzen, S M. (1996). Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. Int. J. Hypertherm. 12(1):3–20. [CSA]
- Prionas, S D., Taylor, N A., Fajardo, L F., Kelly, N I., Nelsen, T S., Hahn, G M. (1985). Thernosensitivity to single and double heat treatment and normal canine liver. Cancer Res. 45(10):4791–4797. [PUBMED], [INFOTRIEVE]
- Robins, H I., Rushing, D., Kutz, M., Tutsch, K D., Tiggelaar, C L., Paul, D., Spriggs, D., Kraemer, C., Gillis, W., Feierabend, C., Arzoomanian, R Z., Longo, W., Alberti, D., d'Oleire, F., Qu, R P., Wilding, G., Stewart, J A. (1997). Phase I clinical trial of carboplatin and 41.8 whole body hyperthermia in cancer patients. J. Clin. Oncol. 15(1):158–164. [PUBMED], [INFOTRIEVE]
- Sminia, P., van der Zee, J., Wondergem, G., Haveman, J. (1994). Effect of hyperthermia on the central nerves system: a review. Int. J. Hypertherm. 10(1):1–30.
- Srivastava, P. (2002). Roles of heat-shock proteins in innate and adaptive immunity. Nat. Rev., Immunol. 2(3):185–194., [CROSSREF]
- Suit, H D., Shwayder, M. (1974). Hyperthermia: potential as an anti-tumor agent. Cancer 34(1):122–129. [PUBMED], [INFOTRIEVE]
- Udono, H., Srivastava, P K. (1994). Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70. J. Immunol. 152(11):5398–5403. [PUBMED], [INFOTRIEVE]
- Wagner, A C., Weber, H., Jonas, L., Nizze, H., Strowski, M., Fiedler, F., Printz, H., Steffen, H., Goke, B. (1996). Hyperthermia induces heat shock protein expression and protection against cerulein-induced pancreatic in rats. Gastroenterology 111(5):1333–1342. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wang, W C., Goldman, L M., Schleider, D M., Appenheimer, M M., Subjeck, J R., Repasky, E A., Evans, S S. (1998). Fever-range hyperthermia enhances l-selectin-dependent adhesion of lymphocytes to vascular endothelium. J. Immunol. 160(2):961–969. [PUBMED], [INFOTRIEVE]
- Wang, X Y., Kazim, L., Repasky, E A., Subjeck, J R. (2001). Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity. J. Immunol. 165(1):490–497.
- Welch, W J. (1992). Mammalian stress response: cell physiology, structure/function of stress proteins, and implications for medicine and disease. Physiol. Rev. 72(4):1063–1081. [PUBMED], [INFOTRIEVE], [CSA]